pros and cons of glp 1 agonists GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness glp 1 drugs pros and

Type 2 diabetes represents a growing challenge for global public health

As California ends Medicaid coverage for GLP-1 weight loss drugs likeWegovy and Zepbound, experts say the states advice to simply eat better isnt realistic for many patients.

Ultrasound assessments could improve risk stratification for perioperative management

The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence

Do GLP-1 patches really work for weight loss and diabetes

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors